The European Society of Cardiology working group on cardiovascular pharmacotherapy.

Eur Heart J Cardiovasc Pharmacother 2022;8: 302-310.) and "Cardiovascular Pharmacotherapy in Women" and "Cardiovascular Pharmacotherapy in Older Persons", which both deal with pharmacological treatments for these specific groups. Covering the whole spectrum of cardiovascular disease, the WG-CVP has been - and continues to be - actively involved in all aspects of cardiovascular pharmacology and pharmacotherapy, from basic and clinical pharmacology to basic research and clinical trials. Created in the 1980s, the ESC Working Group on Cardiovascular Pharmacotherapy (WG-CVP) has gone from strength to strength for over four decades now. [Extracted from the article]